| [1] |
KELLY C, BUSCARINI E, MANFREDI G, et al. Hepatic manifestations of hereditary haemorrhagic telangiectasia[J]. Liver Int, 2024, 44( 9): 2220- 2234. DOI: 10.1111/liv.16008. |
| [2] |
ZENG HJ, TANG SH, QIN S, et al. Progress in the clinical diagnosis and treatment of hepatic vascular diseases[J]. Chin J Hepatol, 2020, 28( 11): 977- 980. DOI: 10.3760/cma.j.cn501113-20200417-00194. |
| [3] |
SHI HT, LU XL. Portal vein thrombosis and hepatic arterio-portal fistula: A re-conceptualization of the diagnosis and treatment[J]. J Pract Hepatol, 2023, 26( 2): 160- 163. DOI: 10.3969/j.issn.1672-5069.2023.02.003. |
| [4] |
BAIGES A, TURON F, SIMÓN-TALERO M, et al. Congenital extrahepatic portosystemic shunts(abernethy malformation): An international observational study[J]. Hepatology, 2020, 71( 2): 658- 669. DOI: 10.1002/hep.30817. |
| [5] |
MURRAY CP, YOO SJ, BABYN PS. Congenital extrahepatic portosystemic shunts[J]. Pediatr Radiol, 2003, 33( 9): 614- 620. DOI: 10.1007/s00247-003-1002-x. |
| [6] |
MATSUURA T, TAKAHASHI Y, YANAGI Y, et al. Surgical strategy according to the anatomical types of congenital portosystemic shunts in children[J]. J Pediatr Surg, 2016, 51( 12): 2099- 2104. DOI: 10.1016/j.jpedsurg.2016.09.046. |
| [7] |
BINKO MA, ANDRASKA EA, REITZ KM, et al. The natural history of portal venous system aneurysms[J]. J Vasc Surg Venous Lymphatic Disord, 2025, 13( 3): 102163. DOI: 10.1016/j.jvsv.2024.102163. |
| [8] |
KURTCEHAJIC A, ZEREM E, ALIBEGOVIC E, et al. Portal vein aneurysm-etiology, multimodal imaging and current management[J]. World J Clin Cases, 2023, 11( 4): 725- 737. DOI: 10.12998/wjcc.v11.i4.725. |
| [9] |
AHMED O, OHMAN JW, VACHHARAJANI N, et al. Feasibility and safety of non-operative management of portal vein aneurysms: A thirty-five year experience[J]. Hpb, 2021, 23( 1): 127- 133. DOI: 10.1016/j.hpb.2020.05.006. |
| [10] |
PARK SO, WANKHEDE M, LEE YJ, et al. Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia[J]. J Clin Invest, 2009, 119( 11): 3487- 3496. DOI: 10.1172/jci39482. |
| [11] |
BUSCARINI E, DANESINO C, OLIVIERI C, et al. Doppler ultrasonographic grading of hepatic vascular malformations in hereditary hemorrhagic telangiectasia- results of extensive screening[J]. Ultraschall Med, 2004, 25( 5): 348- 355. DOI: 10.1055/s-2004-813549. |
| [12] |
MEMEO M, STABILE IANORA AA, SCARDAPANE A, et al. Hepatic involvement in hereditary hemorrhagic telangiectasia:[J]. Abdom Imag, 2004, 29( 2): 211- 220. DOI: 10.1007/s00261-003-0101-3. |
| [13] |
BUSCARINI E, LEANDRO G, CONTE D, et al. Natural history and outcome of hepatic vascular malformations in a large cohort of patients with hereditary hemorrhagic teleangiectasia[J]. Dig Dis Sci, 2011, 56( 7): 2166- 2178. DOI: 10.1007/s10620-011-1585-2. |
| [14] |
European Association for the Study of the Liver. EASL clinical practice guidelines: Vascular diseases of the liver[J]. J Hepatol, 2016, 64( 1): 179- 202. DOI: 10.1016/j.jhep.2015.07.040. |
| [15] |
SHOVLIN CL, GUTTMACHER AE, BUSCARINI E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia(Rendu-Osler-Weber syndrome)[J]. Am J Med Genet, 2000, 91( 1): 66- 67. DOI: 3.0.co;2-p">10.1002/(sici)1096-8628(20000306)91: 1<66:: aid-ajmg12>3.0.co;2-p.
|
| [16] |
FAUGHNAN ME, MAGER JJ, HETTS SW, et al. Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia[J]. Ann Intern Med, 2021, 174( 7): 1035- 1036. DOI: 10.7326/l21-0067. |
| [17] |
BUSCARINI E, BOTELLA LM, GEISTHOFF U, et al. Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia[J]. Orphanet J Rare Dis, 2019, 14( 1): 28. DOI: 10.1186/s13023-018-0982-4. |
| [18] |
AL-SAMKARI H. Systemic antiangiogenic therapies for bleeding in hereditary hemorrhagic telangiectasia: A practical, evidence-based guide for clinicians[J]. Semin Thromb Hemost, 2022, 48( 5): 514- 528. DOI: 10.1055/s-0042-1743467. |
| [19] |
DUPUIS-GIROD S, GINON I, SAURIN JC, et al. Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output[J]. JAMA, 2012, 307( 9): 948- 955. DOI: 10.1001/jama.2012.250. |
| [20] |
NING SL, XU YF, LU WD, et al. Laparoscopic double hepatic artery banding/ligation for patients with hepatic hereditary haemorrhagic telangiectasia(HHHT)[J]. EJVES Vasc Forum, 2023, 60: 73- 76. DOI: 10.1016/j.ejvsvf.2023.09.007. |
| [21] |
LI LL, YU SP. Classification and treatment progress of hepatic artery-portal vein fistula[J]. J Pract Med Imag, 2014, 15( 4): 286- 288.
李玲玲, 于世平. 肝动脉-门静脉瘘的分类及治疗进展[J]. 实用医学影像杂志, 2014, 15( 4): 286- 288.
|
| [22] |
European Association for the Study of the Liver. EASL Clinical Practice Guidelines on vascular diseases of the liver[J]. J Hepatol, 2026, 84( 2): 399- 456. DOI: 10.1016/j.jhep.2025.08.001. |
| [23] |
CITONE M, ANNESE A, GABBANI G, et al. Hepatic barrage to high-flow, intra-hepatic arteroportal fistulas requiring combined interventional approach[J]. BJR|Case Rep, 2025, 11( 4): uaaf034. DOI: 10.1093/bjrcr/uaaf034. |
| [24] |
HOWARD ER, DAVENPORT M. Congenital extrahepatic portocaval shunts: The Abernethy malformation[J]. J Pediatr Surg, 1997, 32( 3): 494- 497. DOI: 10.1016/s0022-3468(97)90614-x. |
| [25] |
Committee on Liver Diseases(Integrated Traditional Chinese and Western Medicine), China Research Hospital Association; Committee on Interventional Medicine, China Research Hospital Association; Branch for Multidisciplinary Diagnosis and Treatment of Portal Hypertension, Beijing Medical Doctor Association. Expert consensus on clinical practice for the diagnosis and treatment of hepatic vascular diseases(2026 edition)[J]. J Clin Hepatol, 2026, 42( 1): 47- 65. DOI: 10.12449/JCH260107. 中国研究型医院学会肝病(中西医结合)专业委员会, 中国研究型医院学会介入医学专业委员会, 北京医师协会门静脉高压症多学科诊治医师分会. 肝脏血管性疾病诊治临床实践专家共识(2026年版)[J]. 临床肝胆病杂志, 2026, 42( 1): 47- 65. DOI: 10.12449/JCH260107. |
| [26] |
RAJESWARAN S, JOHNSTON A, GREEN J, et al. Abernethy malformations: Evaluation and management of congenital portosystemic shunts[J]. J Vasc Interv Radiol, 2020, 31( 5): 788- 794. DOI: 10.1016/j.jvir.2019.08.007. |
| [27] |
CHOCARRO G, AMESTY MV, ENCINAS JL, et al. Congenital portosystemic shunts: Clinic heterogeneity requires an individual management of the patient[J]. Eur J Pediatr Surg, 2016, 26( 1): 74- 80. DOI: 10.1055/s-0035-1566097. |
DownLoad:
